Zimmer Biomet reports strong U.S. growth and robotics gains in Q3 2025, but trims revenue outlook amid global headwinds.
Zimmer Biomet beats Q3 earnings estimates with strong U.S. sales, driven by new products, while reaffirming 2025 guidance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback